G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy

33Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

Abstract

Multiple system atrophy (MSA) is characterized clinically by Parkinsonism, cerebellar dysfunction, and autonomic impairment. Multiple mutations in the LRRK2 gene are associated with parkinsonian disorders, and the most common one, the G2019S mutation, has been found in ∼1% of sporadic cases of Parkinsonism. In a well-characterized cohort of 136 subjects with probable MSA and 110 neurologically evaluated control subjects, none carried the G2019S mutation. We conclude that the G2019S mutation in the LRRK2 gene is unlikely to be associated with MSA. © 2007 Movement Disorder Society.

Cite

CITATION STYLE

APA

Ozelius, L. J., Foroud, T., May, S., Senthil, G., Sandroni, P., Low, P. A., … Ozelius, L. (2007). G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Movement Disorders, 22(4), 546–549. https://doi.org/10.1002/mds.21343

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free